-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Encompass Health, Lowers Price Target to $140

Benzinga·05/05/2026 14:23:50
Listen to the news
Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and lowers the price target from $153 to $140.